Archive: Company News

Company News: Curetis To Attend Key Conferences in the Third Quarter of 2019

Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that the Company will be attending several key conferences in the third quarter of 2019.

Read more…

Company News: Curetis Reports Results of the Annual General Meeting Held on June 27, 2019

– All proposed AGM resolutions approved by shareholders

Curetis N.V. (the “Company” and together with its subsidiaries “Curetis“), a developer of next-level molecular diagnostic solutions, today  reported the results of its Annual General Meeting (“AGM”) held in Amsterdam on June 27, 2019.

Read more…

Company News: VesselSens: First Research Group at Life Science Inkubator Bonn to Receive Funding from EXIST Program

              

— Preclinical development of an implantable sensor system for the wireless detection of vascular constriction funded with EUR 1 mn

VesselSens is the first research group based at Life Science Inkubator (LSI) Bonn, Germany, to receive funding from the EXIST Transfer of Research Program by Germany’s Federal Ministry of Economic Affairs and Energy (BMWi). VesselSens is developing novel sensor technologies for the early, non-invasive detection of a recurrent vascular constriction at the site of an implanted stent (restenosis). Read more…

Company News: Clickmer Systems Receives EUR 1.73 Million for the Development of Novel Synthetic Detection Reagents for Medical Research and Diagnostics

Supported by Life Science Inkubator (LSI) Bonn

— Alternative to antibody-based detection with improved reproducibility and reliability

Clickmer Systems, a spin-off from the University of Bonn, Germany, today announced its incubation at Life Science Inkubator (LSI) Bonn. With the incubation, the project team has not only secured funds totaling EUR 1.73 million from the German Ministry of Education and Research (BMBF), but also gains access to the LSI infrastructure and support from seasoned life science professionals in LSI’s network. This will allow the team to further advance its technology and build an attractive product pipeline. Read more…

1 59 60 61 172